by Team Small News | Dec 1, 2025 | Cipla, Pharma
Cipla, a leading pharmaceutical company, has launched a dedicated lung health diagnostics centre in Delhi, India. This initiative is part of the company’s efforts to reimagine Indian healthcare and provide comprehensive care to patients with respiratory... by Team Small News | Nov 30, 2025 | Natco, Pharma
Natco Pharma, a prominent pharmaceutical company, has recently had its credit rating reaffirmed, accompanied by an enhancement of its credit limits. This development is a testament to the company’s robust financial profile and its ability to maintain a strong... by Team Small News | Nov 30, 2025 | Pharma
The Indian pharmaceutical sector is witnessing significant growth with global majors expanding their presence in advanced therapies. Recently, the Central Drugs Standard Control Organization (CDSCO) granted approval to Eli Lilly’s India subsidiary for Kisunla... by Team Small News | Nov 29, 2025 | Mankind, Pharma
A CDSCO (Central Drugs Standard Control Organization) panel has instructed Mankind Pharma to conduct a Phase I clinical trial for Sintilimab Injection in India before proceeding to Phase III trials. Sintilimab is a recombinant humanized monoclonal antibody used for... by Team Small News | Nov 29, 2025 | Cipla, Pharma
Cipla, a leading pharmaceutical company, has launched India’s first fully integrated Breathefree Lung Wellness Center in Delhi. The center, located in Lajpat Nagar, offers a comprehensive range of services, including over 60 diagnostic tests, pulmonary... by Team Small News | Nov 28, 2025 | Lupin, Pharma
The Golden Cross is a technical indicator that suggests a trend reversal from bearish to bullish, occurring when the 50-day moving average (DMA) moves above the 200 DMA. For Lupin, a pharmaceutical company, this event may mark the beginning of a recovery phase after a...